114 related articles for article (PubMed ID: 3578410)
1. Intrauterine administration of methyl cyanoacrylate as an outpatient method of permanent female sterilization.
Richart RM; Neuwirth RS; Goldsmith A; Edelman DA
Am J Obstet Gynecol; 1987 Apr; 156(4):981-7. PubMed ID: 3578410
[TBL] [Abstract][Full Text] [Related]
2. Transcervical sterilization with use of methyl 2-cyanoacrylate and a newer delivery system (the FEMCEPT device).
Shuber J
Am J Obstet Gynecol; 1989 Apr; 160(4):887-9. PubMed ID: 2712121
[TBL] [Abstract][Full Text] [Related]
3. Trials with the FEMCEPT method of female sterilization and experience with radiopaque methylcyanoacrylate.
Neuwirth RS; Richart RM; Bolduc LR; Krall RE
Am J Obstet Gynecol; 1983 Apr; 145(8):948-54. PubMed ID: 6340511
[TBL] [Abstract][Full Text] [Related]
4. The use of methyl cyanoacrylate (MCA) for female sterilization. Program for Applied Research on Fertility Regulation Northwestern University Medical School Chicago, Illinois.
Contraception; 1985 Mar; 31(3):243-52. PubMed ID: 3995961
[TBL] [Abstract][Full Text] [Related]
5. An outpatient approach to female sterilization with methylcyanoacrylate.
Neuwirth RS; Richart RM; Stevenson T; Bolduc LR; Zinser H; Baur H; Cohen J; Eldering G; Rivas GA; Nilsen PA
Am J Obstet Gynecol; 1980 Apr; 136(7):951-6. PubMed ID: 6987876
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic study of fallopian tube closure after single transcervical insertion of quinacrine pellets.
Merchant RN; Prabhu SR; Kessel E
Int J Fertil Menopausal Stud; 1995; 40(1):47-54. PubMed ID: 7749435
[TBL] [Abstract][Full Text] [Related]
7. [Non-surgical tubal occlusion: use of methylcyanoacrylate and the FEMCEPT device].
Díaz-Sánchez V; Onega MC; Quiroz F; Domenzáin M; Wilson E; Pérez-Palacios G
Rev Invest Clin; 1986; 38(4):383-7. PubMed ID: 3563141
[No Abstract] [Full Text] [Related]
8. Hysteroscopic tubal occlusion using iso-amyl-2-cyanoacrylate in patients with hydrosalpinx.
Amer MIM; Ahmed ME; Hassan DA
J Obstet Gynaecol Res; 2018 Dec; 44(12):2174-2180. PubMed ID: 30058273
[TBL] [Abstract][Full Text] [Related]
9. Sterilization with methyl cyanoacrylate-induced fallopian tube occlusion from a nonsurgical transvaginal approach in rabbits.
Berkey GS; Nelson R; Zuckerman AM; Dillehay D; Cope C
J Vasc Interv Radiol; 1995; 6(5):669-74. PubMed ID: 8541665
[TBL] [Abstract][Full Text] [Related]
10. Selective salpingography and fallopian tubal occlusion with n-butyl-2-cyanoacrylate: report of two cases.
Pelage JP; Herbreteau D; Paillon JF; Murray JM; Rymer R; Garance P
Radiology; 1998 Jun; 207(3):809-12. PubMed ID: 9609908
[TBL] [Abstract][Full Text] [Related]
11. Tubal perforation by Essure: three different clinical presentations.
Langenveld J; Veersema S; Bongers MY; Koks CA
Fertil Steril; 2008 Nov; 90(5):2011.e5-10. PubMed ID: 18692813
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopically applied hemoclips for tubal sterilization.
Wheeless CR
Obstet Gynecol; 1974 Nov; 44(5):752-6. PubMed ID: 4278963
[TBL] [Abstract][Full Text] [Related]
13. Pressure dynamics in the non-gravid uterus: intrauterine pressure cannot confirm tubal occlusion after non-surgical permanent contraception.
Patil E; Thurmond A; Edelman A; Fu R; Lambert W; Seguin J; Jensen JT
Contraception; 2017 Nov; 96(5):330-335. PubMed ID: 28687179
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in the ultrasound follow-up of the Essure micro-insert: complications and proper placement.
Thiel J; Suchet I; Tyson N; Price P
J Obstet Gynaecol Can; 2011 Feb; 33(2):134-138. PubMed ID: 21352631
[TBL] [Abstract][Full Text] [Related]
15. The incidence of asymptomatic uterine anomalies in women undergoing transcervical tubal sterilization.
Ashton D; Amin HK; Richart RM; Neuwirth RS
Obstet Gynecol; 1988 Jul; 72(1):28-30. PubMed ID: 3380507
[TBL] [Abstract][Full Text] [Related]
16. Female sterilization with quinacrine using hysterosalpingography (HSG) as an endpoint after a single-insertion protocol in Caracas, Venezuela.
Giugni Chalbaud A; Plaza Mora G
Int J Gynaecol Obstet; 2003 Oct; 83 Suppl 2():S107-11. PubMed ID: 14763195
[TBL] [Abstract][Full Text] [Related]
17. Pre-hysterectomy assessment of immediate tubal occlusion with the third-generation ESSURE insert (ESS505).
Thiel J; Rattray D; Cher DJ
J Minim Invasive Gynecol; 2014; 21(6):1055-60. PubMed ID: 24861649
[TBL] [Abstract][Full Text] [Related]
18. Characterization of tubal occlusion after transcervical polidocanol foam (PF) infusion in baboons.
Jensen JT; Hanna C; Yao S; Bauer C; Morgan TK; Slayden OD
Contraception; 2015 Aug; 92(2):96-102. PubMed ID: 26070857
[TBL] [Abstract][Full Text] [Related]
19. Hysteroscopic sterilization.
Quiñones R; Alvarado A; Ley E
Int J Gynaecol Obstet; 1976; 14(1):27-34. PubMed ID: 10189
[No Abstract] [Full Text] [Related]
20. [Closure of the skin with cyanoacrylate in surgical wounds after tubal sterilization].
Gorozpe Calvillo JI; González-Villamil J; Santoyo-Haro S; Castañeda-Vivar JJ
Ginecol Obstet Mex; 1997 Feb; 65():64-7. PubMed ID: 9102376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
